Brooks Laboratories Limited (BROOKS) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.003x

Based on the latest financial reports, Brooks Laboratories Limited (BROOKS) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs3.19 Million ≈ $34.55K USD) by net assets (Rs1.16 Billion ≈ $12.51 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BROOKS net asset quality index to measure how much of total assets are equity-financed.

Brooks Laboratories Limited - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Brooks Laboratories Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Brooks Laboratories Limited's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Brooks Laboratories Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Brooks Laboratories Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Korea Computer Terminal Inc KQ:089150	-0.026x
Digital Currency X Technology Inc. NASDAQ:DCX	-0.005x
GUANGDONG KANG.CO.LTD YC1 F:E9Q	N/A
IQuest Co. Ltd. KQ:262840	0.001x
Elve S.A AT:ELBE	0.030x
Energoaparatura S.A. WAR:ENP	-0.357x
Mountain Alliance AG XETRA:ECF	-0.021x
Ever Shine Textile Industry JK:ESTI	0.027x

Annual Cash Flow Conversion Efficiency for Brooks Laboratories Limited (2007–2025)

The table below shows the annual cash flow conversion efficiency of Brooks Laboratories Limited from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see Brooks Laboratories Limited (BROOKS) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs981.04 Million ≈ $10.61 Million	Rs17.62 Million ≈ $190.59K	0.018x	+112.17%
2024-03-31	Rs655.85 Million ≈ $7.09 Million	Rs-96.81 Million ≈ $-1.05 Million	-0.148x	+24.67%
2023-03-31	Rs739.53 Million ≈ $8.00 Million	Rs-144.91 Million ≈ $-1.57 Million	-0.196x	+29.70%
2022-03-31	Rs1.34 Billion ≈ $14.53 Million	Rs-374.41 Million ≈ $-4.05 Million	-0.279x	-594.81%
2021-03-31	Rs791.48 Million ≈ $8.56 Million	Rs44.59 Million ≈ $482.19K	0.056x	+159.05%
2020-03-31	Rs984.16 Million ≈ $10.64 Million	Rs-93.89 Million ≈ $-1.02 Million	-0.095x	-98.66%
2019-03-31	Rs1.05 Billion ≈ $11.37 Million	Rs-50.49 Million ≈ $-546.08K	-0.048x	+11.07%
2018-03-31	Rs1.14 Billion ≈ $12.38 Million	Rs-61.81 Million ≈ $-668.48K	-0.054x	-169.74%
2017-03-31	Rs1.24 Billion ≈ $13.41 Million	Rs96.01 Million ≈ $1.04 Million	0.077x	+16.39%
2016-03-31	Rs1.22 Billion ≈ $13.20 Million	Rs81.19 Million ≈ $878.02K	0.067x	+248.09%
2015-03-31	Rs1.11 Billion ≈ $12.05 Million	Rs21.29 Million ≈ $230.26K	0.019x	-81.66%
2014-03-31	Rs1.12 Billion ≈ $12.14 Million	Rs116.98 Million ≈ $1.27 Million	0.104x	+103.74%
2013-03-31	Rs1.05 Billion ≈ $11.40 Million	Rs53.90 Million ≈ $582.89K	0.051x	+361.70%
2012-03-31	Rs912.63 Million ≈ $9.87 Million	Rs-17.83 Million ≈ $-192.84K	-0.020x	-109.59%
2011-03-31	Rs194.27 Million ≈ $2.10 Million	Rs39.59 Million ≈ $428.16K	0.204x	-51.15%
2010-03-31	Rs136.42 Million ≈ $1.48 Million	Rs56.91 Million ≈ $615.45K	0.417x	+144.20%
2009-03-31	Rs85.37 Million ≈ $923.22K	Rs14.58 Million ≈ $157.71K	0.171x	-58.33%
2008-03-31	Rs49.11 Million ≈ $531.11K	Rs20.13 Million ≈ $217.73K	0.410x	+565.61%
2007-03-31	Rs17.58 Million ≈ $190.16K	Rs1.08 Million ≈ $11.71K	0.062x	--

About Brooks Laboratories Limited

NSE:BROOKS India Drug Manufacturers - Specialty & Generic

Market Cap

$19.52 Million

Rs1.80 Billion INR

Market Cap Rank

#25154 Global

#1397 in India

Share Price

Rs61.26

Change (1 day)

+0.46%

52-Week Range

Rs37.11 - Rs159.04

All Time High

Rs194.97